(DESS) This sequence was originally known as FADE. It combines both the gradient echoes acquired in FISP and PSIFsequences in separate acquisition periods during a single interpulse interval.
Phase encoding gradients are balanced to maintain the transverse steady state signals.
The frequency encoding gradient is left on for the period of both the echoes, and is incompletely balanced to avoid dark banding artifacts otherwise associated with long TR fully balanced steady state sequences.
The contrast of DESS is quite unique, true T2 or T1 contrast weighting is not possible. There is a strong fluid signal but fat is bright and other soft tissues appear similar to the short TR FISP image.
Used for, e.g. the joints, cartilage and the prostate.
(FIESTA) The fast imaging employing steady state acquisition sequence provides images of fluid filled structures with very short acquisition times. The FIESTA sequence uses the T2 steady state contrast mechanism to provide high SNR images with strong signal from fluid tissues while suppressing background tissue for contrast and anatomic detail of small structures. In addition, the ultra short TR and TE enable extremely short acquisition times - shorter than FSE - and the images can be post
processed using MIP, volume rendering, or 3D navigator techniques.
(TrueFISP) True fast imaging with steady state precession is a coherent technique that uses a fully balanced gradient waveform. The image contrast with TrueFISP is determined by T2*//T1 properties and mostly depending on TR. The speed and relative motion insensitivity of acquisition help to make the technique reliable, even in patients who have difficulty with holding their breath.
Recent advances in gradienthardware have led to a decreased minimum TR. This combined with improved field shimming capabilities and signal to noise ratio, has allowed TrueFISP imaging to become practical for whole-body applications. There's mostly T2* weighting. With the used ultrashort TR-times T1 weighting is almost impossible. One such application is cardiaccine MR with high myocardium-blood contrast.
Spatial and temporal resolution can be substantially improved with this technique, but contrast on the basis of the ratio of T2* to T1 is not sufficiently high in soft tissues. By providing T1 contrast, TrueFISP could then document the enhancement effects of T1 shortening contrast agents. These properties are useful for the anatomical delineation of brain tumors and normal structures. With an increase in SNR ratio with minimum TR, TrueFISP could also depict the enhancement effect in myoma uteri.
True FSIP is a technique that is well suited for cardiacMR imaging. The imaging time is shorter and the contrast between the blood and myocardium is higher than that of FLASH.